BridgeMD
A research study on how well liraglutide works in children with obesity
EU CTIS ID: 2023-508504-38-00
What this study is testing
"To compare the effect of liraglutide 3.0 mg s.c. once daily versus placebo on weight management in children aged 6 to <12 years with obesity"
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- "Informed consent of parent(s) or legally acceptable representative of subject and child assent, as age-appropriate, obtained before any trial-related activities for the Main phase as well as for the Extension phase of the trial. Trial-related activities are any procedures that are carried out as part of the trial, including activities to determine suitability for the trial"
- Male or female, aged 6 to <12 years at the time of signing informed consent
- Tanner stage 1-5 pubertal development at the time of signing informed consent
- BMI ≥95th percentile, on gender and age-specific growth charts (CDC.gov)
- History of failing to lose sufficient weight with lifestyle modification as judged by the investigator
- For T2D Haemoglobin A1c (HbA1c) ≤10.0% (86 mmol/mol) as measured by central laboratory at screening
You likely can't join if
- Nothing written about Key Excl.
The study team makes the final eligibility decision.
Where it's taking place
- Russian Federation
- Mexico
- United States
- India
- Switzerland
- Malaysia
- Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 0-17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Russian Federation; Mexico; United States; India; Switzerland; Malaysia and 1 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.